186 related articles for article (PubMed ID: 7965717)
1. Regulation of [3H]dopamine release from rat striatal slices by sigma receptor ligands.
Gonzalez-Alvear GM; Werling LL
J Pharmacol Exp Ther; 1994 Oct; 271(1):212-9. PubMed ID: 7965717
[TBL] [Abstract][Full Text] [Related]
2. Modulation of [3H]Dopamine release from rat nucleus accumbens by neuropeptide Y may involve a sigma1-like receptor.
Ault DT; Radeff JM; Werling LL
J Pharmacol Exp Ther; 1998 Feb; 284(2):553-60. PubMed ID: 9454797
[TBL] [Abstract][Full Text] [Related]
3. Steroids modulate N-methyl-D-aspartate-stimulated [3H] dopamine release from rat striatum via sigma receptors.
Nuwayhid SJ; Werling LL
J Pharmacol Exp Ther; 2003 Sep; 306(3):934-40. PubMed ID: 12750428
[TBL] [Abstract][Full Text] [Related]
4. Release of [3H]dopamine from guinea pig striatal slices is modulated by sigma1 receptor agonists.
Gonzalez GM; Werling LL
Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):455-61. PubMed ID: 9349631
[TBL] [Abstract][Full Text] [Related]
5. sigma1 Receptors in rat striatum regulate NMDA-stimulated [3H]dopamine release via a presynaptic mechanism.
Gonzalez-Alvear GM; Werling LL
Eur J Pharmacol; 1995 Dec; 294(2-3):713-9. PubMed ID: 8750737
[TBL] [Abstract][Full Text] [Related]
6. Sigma2 (sigma2) receptors as a target for cocaine action in the rat striatum.
Nuwayhid SJ; Werling LL
Eur J Pharmacol; 2006 Mar; 535(1-3):98-103. PubMed ID: 16480713
[TBL] [Abstract][Full Text] [Related]
7. Some of the effects of the selective sigma ligand (+)pentazocine are mediated via a naloxone-sensitive receptor.
Couture S; Debonnel G
Synapse; 2001 Mar; 39(4):323-31. PubMed ID: 11169783
[TBL] [Abstract][Full Text] [Related]
8. Modulation of amphetamine-stimulated [3H]dopamine release from rat pheochromocytoma (PC12) cells by sigma type 2 receptors.
Weatherspoon JK; Werling LL
J Pharmacol Exp Ther; 1999 Apr; 289(1):278-84. PubMed ID: 10087015
[TBL] [Abstract][Full Text] [Related]
9. DuP 734 [1-(cyclopropylmethyl)-4-(2'(4''-fluorophenyl)-2'-oxoethyl)- piperidine HBr], a sigma and 5-hydroxytryptamine2 receptor antagonist: receptor-binding, electrophysiological and neuropharmacological profiles.
Tam SW; Steinfels GF; Gilligan PJ; Schmidt WK; Cook L
J Pharmacol Exp Ther; 1992 Dec; 263(3):1167-74. PubMed ID: 1361572
[TBL] [Abstract][Full Text] [Related]
10. Electrically-evoked dopamine and acetylcholine release from rat striatal slices perfused without magnesium: regulation by glutamate acting on NMDA receptors.
Jin S; Fredholm BB
Br J Pharmacol; 1997 Aug; 121(7):1269-76. PubMed ID: 9257903
[TBL] [Abstract][Full Text] [Related]
11. NPC 16377, a potent and selective sigma-ligand. I. Receptor binding, neurochemical and neuroendocrine profile.
Karbon EW; Abreu ME; Erickson RH; Kaiser C; Natalie KJ; Clissold DB; Borosky S; Bailey M; Martin LA; Pontecorvo MJ
J Pharmacol Exp Ther; 1993 May; 265(2):866-75. PubMed ID: 8388461
[TBL] [Abstract][Full Text] [Related]
12. Regulation of NMDA-induced [3H]dopamine release from rat hippocampal slices through sigma-1 binding sites.
Chaki S; Okuyama S; Ogawa S; Tomisawa K
Neurochem Int; 1998 Jul; 33(1):29-34. PubMed ID: 9694039
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
Monnet FP; de Costa BR; Bowen WD
Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358
[TBL] [Abstract][Full Text] [Related]
14. Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems.
Gronier B; Debonnel G
Eur J Pharmacol; 1999 Mar; 368(2-3):183-96. PubMed ID: 10193654
[TBL] [Abstract][Full Text] [Related]
15. Cooperative contributions of cholinergic and NMDA receptors in the presynaptic control of dopamine release from synaptosomes of the rat striatum.
Chéramy A; Godeheu G; L'Hirondel M; Glowinski J
J Pharmacol Exp Ther; 1996 Feb; 276(2):616-25. PubMed ID: 8632329
[TBL] [Abstract][Full Text] [Related]
16. Sigma1 receptor agonist-mediated regulation of N-methyl-D-aspartate-stimulated [3H]dopamine release is dependent upon protein kinase C.
Nuwayhid SJ; Werling LL
J Pharmacol Exp Ther; 2003 Jan; 304(1):364-9. PubMed ID: 12490613
[TBL] [Abstract][Full Text] [Related]
17. Modulation of amphetamine-stimulated (transporter mediated) dopamine release in vitro by sigma2 receptor agonists and antagonists.
Izenwasser S; Thompson-Montgomery D; Deben SE; Chowdhury IN; Werling LL
Eur J Pharmacol; 1998 Apr; 346(2-3):189-96. PubMed ID: 9652359
[TBL] [Abstract][Full Text] [Related]
18. Distinct modulatory roles of sigma receptor subtypes on glutamatergic responses in the dorsal hippocampus.
Bermack JE; Debonnel G
Synapse; 2005 Jan; 55(1):37-44. PubMed ID: 15499608
[TBL] [Abstract][Full Text] [Related]
19. New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives.
Berardi F; Colabufo NA; Giudice G; Perrone R; Tortorella V; Govoni S; Lucchi L
J Med Chem; 1996 Jan; 39(1):176-82. PubMed ID: 8568804
[TBL] [Abstract][Full Text] [Related]
20. Inhibition by sigma receptor ligand, MS-377, of N-methyl- D-aspartate-induced currents in dopamine neurons of the rat ventral tegmental area.
Yamazaki Y; Ishioka M; Matsubayashi H; Amano T; Sasa M
Psychopharmacology (Berl); 2002 Apr; 161(1):64-9. PubMed ID: 11967632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
